| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.45 | 0.2 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.2 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.2 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.036 | 0.2 |